ÂÜÀòÂÒÂ×

Robert brings over 20 years of drug development experience. He is VP of product development at ILC therapeutics. He was previously the Senior Director of Preclinical at MiroBio. Before this, Robert worked at Oxford Biotherapeutics, where he was UK site head and Scientific Director leading the development of their therapeutic antibody programs in immune-oncology and oncology. Previously Rob has been a Group Leader and Scientific Investigator at the MRC Toxicology Unit and Oxford Glycosciences.